Journal Management System
ScopeMed is an
Online Journal/Article Management system
that can enable all of the operations of
the editorial functions of a journal.
Home  |   Add your Journal  |   Properties of ScopeMed  |   Video Tutorials  |   Journal List
Author Login | Reviewer Login | Editor Login
Search  


National Journal of Physiology, Pharmacy and Pharmacology
Periodical of Mrs Dipika Charan
Journal Home Page
ISSN: 2320-4672 (Print)
ISSN: 2231-3206 (Online)
Language: [ English ]  

  » Volume 3, Issue 1
      pp. 1-101

 

Open Access

Original Research



Relationship between cardiovascular autonomic (dys)function and microalbuminuria in type 2 Diabetes Mellitus

Deepak N Parchwani, Jatin V Dhanani, Amit A Upadhyah, Manojkumar H Sharma, Amit M Shah, Pankaj B Maheria, Kamlesh M Palandurkar.

A B S T R A C TR E F E R E N C E SCited by (2) 

Abstract
Background: Diabetic autonomic neuropathy is a serious and common complication of diabetes mellitus and in fact it is one of the most overlooked complications, thus very limited clinical and research data are available on early renal and cardiovascular autonomic complications in type 2 diabetes mellitus.

Aims & Objective: To determine the possible association of elevated albumin excretion rate with cardiovascular autonomic activity in type 2 diabetes mellitus.

Materials and methods: A cross-sectional study was conducted with one hundred and fifteen patients of type 2 diabetes mellitus. Microalbuminuria was defined as Albumin Excretion Rate (AER) > 30 mg/24 hr in an early morning urine sample. Nine parameters reflecting different aspects of cardiovascular autonomic function were measured and were summarized in a single cardiovascular autonomic function score (CAFS).The association between cardiovascular autonomic dysfunction and microalbuminuria was estimated by multiple linear regressions.

Results: Patients with microalbuminuria had low levels of the autonomic function parameters i.e. mean CAFS, indicating impaired autonomic function. This association was consistent with increasing AER, and remained significant after multivariate adjustment for other clinical factors predictive of microalbuminuria. In additional analysis, we examined the autonomic function tests combined on the part of autonomic nervous system they predominantly represent. The results of these alternative combinations were comparable to those of the CAFS score.

Conclusion: Cardiovascular autonomic dysfunction was independently associated with microalbuminuria in patients with type 2 diabetes mellitus, and that this association is independent of other previously identified determinants of albuminuria in type 2 diabetes mellitus. Therefore cardiovascular autonomic function tests should be monitored to pay attention to major potential cardiovascular complications even in asymptomatic patients, but especially among those with microalbuminuria.

Key words: Microalbuminuria; Cardiovascular Autonomic Function Tests; Type 2 Diabetes Mellitus


ARTICLE TOOLS
Abstract
PDF Fulltext
Email this Article
Print this article Print this Article
How to cite this articleHow to cite this article
Export to
Export to
Related Records
 Articles by Deepak N Parchwani
Articles by Jatin V Dhanani
Articles by Amit A Upadhyah
Articles by Manojkumar H Sharma
Articles by Amit M Shah
Articles by Pankaj B Maheria
Articles by Kamlesh M Palandurkar
on IndexScholar Fulltext
on Google
on Google Scholar
Article Statistics
 Viewed: 517
Downloaded: 336
(Last 7 Days: 1)
Cited: 2
Emailed: 2

REFERENCES
1.Sicree R, Shaw J, Zimmet P. Diabetes and impaired glucose tolerance. In: Gan D, editor. Diabetes Atlas. International Diabetes Federation. 3rd ed.Belgium: International Diabetes Federation;2006;15-103.

2. Faulkner MS, Hathaway DK, Milstead EJ, Burghen GA. Heart rate variability in adolescents and adultswith T1DM. Nursing Research 2001;50(2):95–104.
[
DOI via Crossref]    [Pubmed]   

3. Gerstein HC, Mann JFE, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S, HOPE Study Investigators: Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001;286:421–426.
[
DOI via Crossref]   

4. Stehouwer CD, Smulders YM. Microalbuminuria and risk for cardiovascular disease: analysis of potential mechanisms. J Am Soc Nephrol 2006;17:2106–2111.
[
DOI via Crossref]    [Pubmed]   

5. Hanneke JBH, Beijers, Isabel F, Bert B, Dekker JM, Nijpels G, Heine RJ, COEN DA. Microalbuminuria and Cardiovascular Autonomic Dysfunction Are IndependentlyAssociated With Cardiovascular Mortality:Evidence for Distinct Pathways. Diabetes Care 2009;32:1698–1703.
[
Pubmed]    [PMC Free Fulltext]   

6. Smulders YM, Jager A, Gerritsen J, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD. Cardiovascular autonomic function is associated with (micro-)albuminuria in elderly Caucasian subjects with impaired glucose tolerance or type 2 diabetes: the Hoorn Study. Diabetes Care 2000;23:1369–1374.
[
DOI via Crossref]    [Pubmed]   

7. Yokoyama H, Yokota Y, Tada J, Kanno S. Diabetic neuropathy is closely associated with arterial stiffening and thickness in type 2 diabetes. Diabet Med 2007;24:1329–1335.
[
DOI via Crossref]    [Pubmed]   

8. World health organization expert consultation: Appropriate body mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157-163.
[
DOI via Crossref]   

9. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-2572.
[
DOI via Crossref]    [Pubmed]   

10. Rodicio JL, Campo C, Ruilope LM. Microalbuminuria in essential hypertension. Kidney Int 1998;54:1523–1555.
[
DOI via Crossref]   

11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA2001;285(19):2486-2497.
[
DOI via Crossref]   

12. Vinik AI, Maser RE, Mitchell BD, Freeman R: Diabetic autonomic neuropathy. Diabetes Care 2003;26:1553–1579.
[
DOI via Crossref]    [Pubmed]   

13. Ewing DJ, Martyn CN, Young RJ, Clarke BF: The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 1985;8:491– 498.
[
DOI via Crossref]    [Pubmed]   

14. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D, American Diabetes Association. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005;28:956–962.
[
DOI via Crossref]    [Pubmed]   

15. Imholz BP, Wieling W, van Montfrans GA, Wesseling KH: Fifteen years experience with finger arterial pressure monitoring: assessment of the technology. Cardiovasc Res 1998;38:605–616.
[
DOI via Crossref]   

16. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 1996;93:1043–1065.
[
DOI via Crossref]   

17. Ewing DJ, Clarke BF: Diagnosis and management of diabetic autonomic neuropathy.BMJ 1982;285:916–917.
[
DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   

18. Spallone V, Gambardella S, Maiello MR, Barini A, Frontoni S, Menzinger G: Relationship between autonomic neuropathy, 24-hour blood pressure profile, and nephropathy in normotensive IDDM patients. Diabetes Care 1994;17:578–584.
[
DOI via Crossref]    [Pubmed]   

19. Neil HAW, Thompson AV, John S, McCarthy ST, Mann JI: Diabetic autonomic neuropathy: the prevalence of impaired heart rate variability in a geographically defined population. Diabet Med 1989;6:20–24.
[
DOI via Crossref]    [Pubmed]   

20. Cohen JA, Jeffers BW, Faldut D, Marcoux M, Schrier RW: Risks for sensorimotor peripheral neuropathy and autonomic neuropathy in noninsulin-dependent diabetes mellitus. Muscle Nerve 1998;21:72–80.
[
DOI via Crossref]   

21. Wirta OR, Pasternack AI, Mustonen JT, Laippala PJ, Reinikainen PM: Urinary albumin excretion rate is independently related to autonomic neuropathy in type 2 diabetes mellitus. J Intern Med 1999;245:329–335.
[
DOI via Crossref]    [Pubmed]   

22. Jermendy G, Ferenczi J, Hernandez E, Farkas K, Nadas J: Day–night blood pressure variation in normotensive and hypertensive NIDDM patients with asymptomatic autonomic neuropathy. Diabetes Res Clin Pract 1996;34:107–114.
[
DOI via Crossref]   

23. Ritz E, Stefanski M: Diabetic nephropathy in type II diabetes. Am J Kidney Dis 1996;27:167–194.
[
DOI via Crossref]   

24. Hilsted J: Pathophysiology in diabetic autonomic neuropathy: cardiovascular, hormonal, and metabolic studies. Diabetes 1982;31:730–737.
[
Pubmed]   

25. Strojek K, Grzeszczak W, Gorska J, Leschinger MI, Ritz E: Lowering of microalbuminuria in diabetic patients by a sympathicoplegic agent: novel approach to prevent diabetic nephropathy? J AmSoc Nephrol 2001;12:602–605.
[
Pubmed]   

26. Bigger JT, Fleiss JL, Rolnitzky LM, Steinman RC. The ability of several short-term measures of RR variability to predict mortality after myocardial infarction. Circulation 1993;88:927–934.
[
DOI via Crossref]    [Pubmed]   

27. Gerritsen J, TenVoorde BJ, Dekker JM, Kingma R, Kostense PJ, Bouter LM, Heethaar RM. Measures of cardiovascular autonomic nervous function: agreement, reproducibility, and reference values in middle age and elderly subjects. Diabetologia 2003;46:330–338.
[
Pubmed]   


This Article Cited By the following articles

Trends of articles published in National Journal of Physiology, Pharmacy and Pharmacology NJPPP
National Journal of Physiology, Pharmacy and Pharmacology 2013; 3(2): 102.

1
 
Diabetic nephropathy: Progression and pathophysiology
Int J Med Sci Public Health 2012; 1(2): 59.

2
 

How to Cite this Article
Pubmed Style

Parchwani DN, Dhanani JV, Upadhyah AA, Sharma MH, Shah AM, Maheria PB, Palandurkar KM. Relationship between cardiovascular autonomic (dys)function and microalbuminuria in type 2 Diabetes Mellitus. Natl J Physiol Pharm Pharmacol. 2012; 2(2): 84-92. doi:10.5455/njppp.2012.2.84-92



Web Style

Parchwani DN, Dhanani JV, Upadhyah AA, Sharma MH, Shah AM, Maheria PB, Palandurkar KM. Relationship between cardiovascular autonomic (dys)function and microalbuminuria in type 2 Diabetes Mellitus. www.scopemed.org/?mno=22110 [Access: May 21, 2013]. doi:10.5455/njppp.2012.2.84-92



AMA (American Medical Association) Style

Parchwani DN, Dhanani JV, Upadhyah AA, Sharma MH, Shah AM, Maheria PB, Palandurkar KM. Relationship between cardiovascular autonomic (dys)function and microalbuminuria in type 2 Diabetes Mellitus. Natl J Physiol Pharm Pharmacol. 2012; 2(2): 84-92. doi:10.5455/njppp.2012.2.84-92



Vancouver/ICMJE Style

Parchwani DN, Dhanani JV, Upadhyah AA, Sharma MH, Shah AM, Maheria PB, Palandurkar KM. Relationship between cardiovascular autonomic (dys)function and microalbuminuria in type 2 Diabetes Mellitus. Natl J Physiol Pharm Pharmacol. (2012), [cited May 21, 2013]; 2(2): 84-92. doi:10.5455/njppp.2012.2.84-92



Harvard Style

Parchwani, D. N., Dhanani, J. V., Upadhyah, A. A., Sharma, M. H., Shah, A. M., Maheria, P. B. & Palandurkar, K. M. (2012) Relationship between cardiovascular autonomic (dys)function and microalbuminuria in type 2 Diabetes Mellitus. Natl J Physiol Pharm Pharmacol, 2 (2), 84-92. doi:10.5455/njppp.2012.2.84-92



Turabian Style

Parchwani, Deepak N, Jatin V Dhanani, Amit A Upadhyah, Manojkumar H Sharma, Amit M Shah, Pankaj B Maheria, and Kamlesh M Palandurkar. 2012. Relationship between cardiovascular autonomic (dys)function and microalbuminuria in type 2 Diabetes Mellitus. National Journal of Physiology, Pharmacy and Pharmacology, 2 (2), 84-92. doi:10.5455/njppp.2012.2.84-92



Chicago Style

Parchwani, Deepak N, Jatin V Dhanani, Amit A Upadhyah, Manojkumar H Sharma, Amit M Shah, Pankaj B Maheria, and Kamlesh M Palandurkar. "Relationship between cardiovascular autonomic (dys)function and microalbuminuria in type 2 Diabetes Mellitus." National Journal of Physiology, Pharmacy and Pharmacology 2 (2012), 84-92. doi:10.5455/njppp.2012.2.84-92



MLA (The Modern Language Association) Style

Parchwani, Deepak N, Jatin V Dhanani, Amit A Upadhyah, Manojkumar H Sharma, Amit M Shah, Pankaj B Maheria, and Kamlesh M Palandurkar. "Relationship between cardiovascular autonomic (dys)function and microalbuminuria in type 2 Diabetes Mellitus." National Journal of Physiology, Pharmacy and Pharmacology 2.2 (2012), 84-92. Print. doi:10.5455/njppp.2012.2.84-92



APA (American Psychological Association) Style

Parchwani, D. N., Dhanani, J. V., Upadhyah, A. A., Sharma, M. H., Shah, A. M., Maheria, P. B. & Palandurkar, K. M. (2012) Relationship between cardiovascular autonomic (dys)function and microalbuminuria in type 2 Diabetes Mellitus. National Journal of Physiology, Pharmacy and Pharmacology, 2 (2), 84-92. doi:10.5455/njppp.2012.2.84-92




News / Announcements

  • Journal is Indexed in EMBASE ['Feb 15, 2013']

  • Hard copy of journal ['Feb 11, 2013']


  • » Last Downloads

    Please Wait...




    Total Download: 18.413
    (for National Journal of Physiology, Pharmacy and Pharmacology)
    Total Submission during last 24 hours: 153


    » For Authors




    Become Reviewer


    » Login Area




    Follow ScopeMed on Twitter

    ScopeMed Home | About ScopeMed | Contact Us | Terms & Conditions | Privacy Policy
    The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
    ScopeMed is a Service of SAGE Publishing for Scientific Publications. Copyright © ScopeMed® International Medical Journal Management and Indexing System.